Article Text
PDFDeclarations of Interest
S93 Effect of lumacaftor/ivacaftor on total, bronchiectasis, and air trapping computed tomography (ct) scores in children homozygous for f508del-cftr: exploratory imaging substudy
Abstract
AS Brody reports personal fees from Vertex Pharmaceuticals during the conduct of the study.
S Nagle reports personal consulting fees from Vertex Pharmaceuticals during the conduct of the study; non-financial support from GE Healthcare (institution/department support).
C Hug, G Marigowda, D Waltz, L Wang are employees of Vertex Pharmaceuticals and may hold stock and/or stock options in the company.
J Goldin reports ‘other’ conflicts – Founder of MedQIA during the conduct of the study.
F Ratjen reports grants and personal fees from Vertex Pharmaceuticals, personal consulting fees from Novartis, Bayer, Roche, Genetech, and Prosteostasis.